Accordingly, SAT expression and circulating levels of adiponectin are reduced in obesity and other insulin-resistant conditions [14,15,16], showing a strong inverse relationship with insulin action on substrate metabolism and insulin signalling in skeletal muscle [16,17]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.